Large, multicenter, retrospective study of Colombian dialysis patients indicates cardiovascular events were 35% lower for patients on HDx therapy enabled by Theranova than participants on standard hemodialysis1 Data from study also show HDx therapy may reduce hospitalization rates up to 18%1 DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced […]